Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $6,270 - $6,976
-30 Reduced 1.5%
1,971 $430,000
Q4 2023

Feb 13, 2024

SELL
$197.69 - $227.29 $88,762 - $102,053
-449 Reduced 18.33%
2,001 $454,000
Q3 2023

Nov 08, 2023

SELL
$201.05 - $221.7 $9,248 - $10,198
-46 Reduced 1.84%
2,450 $492,000
Q2 2023

Aug 01, 2023

SELL
$211.93 - $241.33 $2,967 - $3,378
-14 Reduced 0.56%
2,496 $602,000
Q1 2023

May 10, 2023

SELL
$213.32 - $257.83 $114,339 - $138,196
-536 Reduced 17.6%
2,510 $575,000
Q4 2022

Jan 31, 2023

BUY
$203.72 - $248.97 $86,784 - $106,061
426 Added 16.26%
3,046 $716,000
Q3 2022

Oct 27, 2022

BUY
$204.81 - $262.19 $2,457 - $3,146
12 Added 0.46%
2,620 $537,000
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $19,888 - $25,841
-93 Reduced 3.44%
2,608 $611,000
Q1 2022

Apr 28, 2022

SELL
$259.82 - $298.18 $76,127 - $87,366
-293 Reduced 9.79%
2,701 $712,000
Q4 2021

Feb 07, 2022

BUY
$271.6 - $314.21 $88,541 - $102,432
326 Added 12.22%
2,994 $941,000
Q3 2021

Nov 08, 2021

BUY
$274.82 - $308.34 $117,897 - $132,277
429 Added 19.16%
2,668 $751,000
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $125,431 - $138,513
498 Added 28.6%
2,239 $618,000
Q4 2020

Feb 09, 2021

SELL
$186.91 - $214.42 $42,989 - $49,316
-230 Reduced 11.67%
1,741 $354,000
Q3 2020

Oct 29, 2020

SELL
$167.03 - $201.3 $19,542 - $23,552
-117 Reduced 5.6%
1,971 $371,000
Q2 2020

Aug 10, 2020

BUY
$113.31 - $182.44 $453 - $729
4 Added 0.19%
2,088 $347,000
Q1 2020

May 13, 2020

SELL
$104.32 - $195.28 $275,509 - $515,734
-2,641 Reduced 55.89%
2,084 $263,000
Q4 2019

Feb 05, 2020

BUY
$163.48 - $173.61 $155,796 - $165,450
953 Added 25.27%
4,725 $799,000
Q3 2019

Nov 04, 2019

SELL
$159.77 - $178.1 $108,324 - $120,751
-678 Reduced 15.24%
3,772 $634,000
Q2 2019

Aug 01, 2019

SELL
$144.16 - $172.9 $90,820 - $108,927
-630 Reduced 12.4%
4,450 $769,000
Q1 2019

May 08, 2019

SELL
$123.7 - $156.3 $28,451 - $35,949
-230 Reduced 4.33%
5,080 $777,000
Q4 2018

Jan 30, 2019

SELL
$120.82 - $174.09 $109,704 - $158,073
-908 Reduced 14.6%
5,310 $671,000
Q3 2018

Nov 08, 2018

BUY
$167.67 - $188.27 $396,707 - $445,446
2,366 Added 61.42%
6,218 $1.08 Million
Q2 2018

Aug 08, 2018

BUY
$160.33 - $189.41 $25,652 - $30,305
160 Added 4.33%
3,852 $692,000
Q1 2018

May 15, 2018

BUY
$161.53 - $178.11 $21,968 - $24,222
136 Added 3.82%
3,692 $597,000
Q4 2017

Feb 08, 2018

SELL
$147.99 - $163.95 $94,713 - $104,928
-640 Reduced 15.25%
3,556 $567,000
Q3 2017

Nov 02, 2017

SELL
$149.47 - $160.56 $7,772 - $8,349
-52 Reduced 1.22%
4,196 $633,000
Q2 2017

May 14, 2018

SELL
N/A
-938 Reduced 18.09%
4,248 $655,000
Q1 2017

May 14, 2018

SELL
N/A
-100 Reduced 1.89%
5,186 $744,000
Q4 2016

May 14, 2018

BUY
N/A
5,286
5,286 $679,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.